Dan Alldridge

Co-founded a pediatric medtech startup as COO, leading operations and business readiness through pre-seed fundraising. Owns operational and regulatory strategy for the FDA Class I Exempt device, including market entry planning.

Independent operations consultancy providing post-M&A integration, new product introduction, and go-to-market operational strategy for life-science and diagnostics clients.

As Chairman of the Board (Utah), grew the annual budget from $750K to $2.5M and athlete participation from 2,000 to 7,000. Lead a statewide board of 15+ and serve on the International Sport & Competition Committee.

Volunteer and adaptive sports coach.

Led global operations including manufacturing, supply chain, and distribution, managing a team of 6 and a network of contract manufacturers. Scaled operations to support 250%+ YoY growth and reduced costs through vendor consolidation and logistics improvements.

Held two leadership roles overseeing supply chain and program management. Improved on-time delivery from 65% to 90% by rebuilding production scheduling, scaled operations to multiple sites, and directed technology transfers for 70+ clients.

Individual contributor role owning operations and vendor network for a single-cell genomics startup. Cut consumable COGS by over 60%, built global supplier network, and scaled operations from Series A to $20M+ revenue, contributing to acquisition by Bio-Rad.

Managed a $13.6M P&L and authored a 5-year strategy for the MassARRAY systems/software portfolio, achieving 30% business growth. Owned global product roadmap, launch execution, and voice-of-customer across hardware and software.

Directed $750M+ in cumulative global procurement spend across teams at 15 sites, consistently delivering the division's 4% annual cost-savings target.

Proposed, created, and built Thermo Fisher's NPI Procurement team from scratch, growing it to 7 people covering 10 manufacturing sites. Institutionalized an NPI procurement framework adopted company-wide.

Supported operations through Thermo Fisher's acquisition of Life Technologies, capturing $7.2M in cost savings through material transitions and labor agreement renegotiations.

Managed 50+ external partner relationships and oversaw hundreds of millions in annual outsourced spend. Rationalized make-vs-buy portfolio and led post-acquisition peptide consolidation.

Led teams through multiple combat deployments in Iraq and Afghanistan, recognized for valor and high performance. Developed and executed civil-planning strategies improving local governance and services in Iraq.

Earned a Master of Science in Strategic Management in 2016 and an MBA in 2015 from Indiana University's Kelley School of Business.

Earned an MBA from Indiana University's Kelley School of Business in 2015.

Earned a Bachelor of Science in Sociology and Criminology from Southern Illinois University in 2006.